Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-15-025769

SVP & Chief Medical Officer sold 8,940 shares at $10.54 ($94,228)

  • SVP & Chief Medical Officer acquired 17,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Paolo · SVP & Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2015-03-10 Exercise or conversion : show line 1 in the form +12,500 34,485 D
2015-03-10 Exercise or conversion : show line 2 in the form +5,000 39,485 D
2015-03-10 Sale : show line 3 in the form −8,940 $10.54 $94,228 30,545 D
Open-market sales · 8,940 sh · avg $10.54 · $94,228

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2015-03-10 Exercise or conversion : show line 4 in the form Restricted Stock Unit −12,500 12,500 25,000 D
2015-03-10 Exercise or conversion : show line 5 in the form Restricted Stock Unit −5,000 5,000 15,000 D
Loading xslF345X03/doc4.xml…